A Study to Assess the Genotype of Subjects with Diagnosis of Ulcerative Colitis or Crohn's Disease (The PRELUDE Study)
- Study HIC#:2000031352
- Last Updated:01/01/0001
Researchers are trying to develop a more targeted approach to treat ulcerative colitis (UC) and Crohn’s disease (CD). This research study will help develop tests that may indicate how well patients will respond to different therapies in the future.
Your participation in this study is expected to last from 1 to 35 days and is expected to include 1 to 2 study visits to the study center. If the original sample(s) you provide are not usable, you will be asked to provide additional sample(s). You will not be asked to provide more than one additional sample.
- Age18 years and older
- GenderBoth
Contact Us
For more information about this study, including how to volunteer, contact:
Elizabeth Ruggiero
- Phone Number: 1-203-785-4576
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
Researchers are trying to develop a more targeted approach to treat ulcerative colitis (UC) and Crohn’s disease (CD). This research study will help develop tests that may indicate how well patients will respond to different therapies in the future.
Your participation in this study is expected to last from 1 to 35 days and is expected to include 1 to 2 study visits to the study center. If the original sample(s) you provide are not usable, you will be asked to provide additional sample(s). You will not be asked to provide more than one additional sample.
Eligibility Criteria
Inclusion Criteria:
1. Male or female and aged ≥ 18.
2. Diagnosis of ulcerative colitis (UC) or Crohn’s disease (CD) established prior to screening by clinical and endoscopic evidence and corroborated by a histopathology report.
3. Currently on at least 1 approved therapy for UC or CD
